Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Scott

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
Angewandte Chemie (International Ed. in English)|August 20, 2021
Discovery and Characterisation of Highly Cooperative FAK-Degrading PROTACsRobert P Law, Joao Nunes, Chun-Wa Chung, et al.
European Journal of Clinical Investigation|May 22, 2022
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEFAldostefano Porcari, Marco Merlo, Chiara Baggio, et al.
Genome Research|March 26, 2013
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without cultureHelena M B Seth-Smith, Simon R Harris, Rachel J Skilton, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2009
Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humansJohn R Atack, Dean F Wong, Tim D Fryer, et al.
Journal of Medicinal Chemistry|January 29, 2019
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesGraham L Simpson, Sophie M Bertrand, Jennifer A Borthwick, et al.
Journal of the American Heart Association|January 19, 2024
High Prevalence of New Clinically Significant Findings in Patients With Embolic Stroke of Unknown Source Evaluated by Cardiac Magnetic Resonance ImagingIrum D Kotadia, Robert O'Dowling, Akosua Aboagye, et al.
Communications Biology|March 22, 2020
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2Alina Mares, Afjal H Miah, Ian E D Smith, et al.
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Health and Quality of Life Outcomes|June 14, 2017
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease ModuleJulie A Panepinto, J Paul Scott, Oluwakemi Badaki-Makun, et al.
Blood|August 2, 2015
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in childrenDavid C Brousseau, J Paul Scott, Oluwakemi Badaki-Makun, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Angewandte Chemie (International Ed. in English)|August 20, 2021
Discovery and Characterisation of Highly Cooperative FAK-Degrading PROTACsRobert P Law, Joao Nunes, Chun-Wa Chung, et al.
European Journal of Clinical Investigation|May 22, 2022
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEFAldostefano Porcari, Marco Merlo, Chiara Baggio, et al.
Genome Research|March 26, 2013
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without cultureHelena M B Seth-Smith, Simon R Harris, Rachel J Skilton, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2009
Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humansJohn R Atack, Dean F Wong, Tim D Fryer, et al.
Journal of Medicinal Chemistry|January 29, 2019
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesGraham L Simpson, Sophie M Bertrand, Jennifer A Borthwick, et al.
Journal of the American Heart Association|January 19, 2024
High Prevalence of New Clinically Significant Findings in Patients With Embolic Stroke of Unknown Source Evaluated by Cardiac Magnetic Resonance ImagingIrum D Kotadia, Robert O'Dowling, Akosua Aboagye, et al.
Communications Biology|March 22, 2020
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2Alina Mares, Afjal H Miah, Ian E D Smith, et al.
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Health and Quality of Life Outcomes|June 14, 2017
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease ModuleJulie A Panepinto, J Paul Scott, Oluwakemi Badaki-Makun, et al.
Blood|August 2, 2015
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in childrenDavid C Brousseau, J Paul Scott, Oluwakemi Badaki-Makun, et al.
Pageof 26